Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Corporate Governance
2011.09.15
独立董事关于第二届董事会第七次会议相关议案的独立意见
2011.08.19
独立董事关于对公司关联方资金往来及对外担保情况的独立意见
2011.08.19
独立董事关于第二届董事会第六次会议相关议案的独立意见
2011.07.30
独立董事关于第二届董事会第五次会议相关议案的独立意见
2011.07.30
对外捐赠管理制度（2011年7月）
2011.05.28
独立董事关于公司治理专项活动的整改报告的独立意见
2011.04.18
独立董事关于在深圳市投资设立合资公司的独立意见
2011.03.28
独立董事2010年度述职报告
2011.03.28
公司章程（2011年3月）
2011.03.28
独立董事对第二届董事会第二次会议相关事项的独立意见
第一页
上一页
20
21
22
23
24
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
